Clinical Trials Register

Trials with a EudraCT protocol (320)
Paediatric studies in scope of Art45 of the Paediatric Regulation (10)

320 result(s) found for: Sleep Disorder. Displaying page 16 of 16.

EudraCT Number: 2010-021448-17

Sponsor Protocol Number: CBGG492A2212

Start Date*: 2011-02-16

Sponsor Name:Novartis Pharma Services AG

Full Title: A multicenter, open-label, follow-up study to evaluate the long-term safety and tolerability of BGG492 TID as adjunctive therapy in patients with partial onset seizures completing double-blind, pla...

Medical condition: Epilepsy Partial onset seizures

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10065336	Partial epilepsy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) DE (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2021-000764-30

Sponsor Protocol Number: HOT-LOCO

Start Date*: 2021-07-06

Sponsor Name:Karolinska University Hospital

Full Title: Hyperbaric Oxygen for Treatment of Long COVID syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical Trial

Medical condition: Long COVID, post-acute COVID-19 Syndrome, post COVID-19 Syndrome (ICD-10 U09.0)

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT
	20.1	10021881 - Infections and infestations	10057244	Post viral fatigue syndrome	PT
	20.0	10007541 - Cardiac disorders	10063080	Postural orthostatic tachycardia syndrome	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: (No results available)

EudraCT Number: 2021-005855-35

Sponsor Protocol Number: U1111-1270-0943

Start Date*: 2023-01-10

Sponsor Name:NOVO NORDISK. S.P.A.

Full Title: The cardiovascular safety of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants with obesity and established cardiovascu...

Medical condition: Atherosclerotic cardiovascular disease and Obesity

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	100000004866	10051615	Atherosclerotic cardiovascular disease	LLT
	20.0	10027433 - Metabolism and nutrition disorders	10029883	Obesity	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Trial now transitioned) IE (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) NL (Trial now transitioned) BG (Trial now transitioned) DK (Trial now transitioned) FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2011-002277-38

Sponsor Protocol Number: MT-06

Start Date*: 2011-10-06

Sponsor Name:ALK-Abelló A/S

Full Title: A one-year trial evaluating the efficacy and safety of the ALK house dust mite allergy immunotherapy tablet in adult subjects with house dust mite allergic rhinitis

Medical condition: allergic rhinitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10034382	Perennial allergic rhinitis	LLT
	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10001723	Allergic rhinitis	LLT
	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10001724	Allergic rhinitis (excl hay fever)	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) CZ (Completed) LV (Completed) DK (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2013-005163-10

Sponsor Protocol Number: DS5565-A-E311

Start Date*: 2014-12-18

Sponsor Name:Daiichi Sankyo Development Ltd

Full Title: A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 in Subjects with Pain Associated with Fibromyalgia

Medical condition: DS-5565 is being developed for the treatment of pain associated with fibromyalgia (FM).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10028395 - Musculoskeletal and connective tissue disorders	10048439	Fibromyalgia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) SK (Completed) EE (Completed) LT (Completed) HU (Completed) LV (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2008-005778-11

Sponsor Protocol Number: NP031112-08B03

Start Date*: 2009-01-29

Sponsor Name:Noscira S.A.

Full Title: A 14 week double-blind, placebo-controlled, randomized, escalating dose study to evaluate the safety and tolerability of three oral doses of NP031112, a novel GSK3 inhibitor, in mild to moderate Al...

Medical condition: Alzheimer's Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10001896	Alzheimer's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2008-002455-25

Sponsor Protocol Number: BIA-2093-304

Start Date*: 2008-09-18

Sponsor Name:BIAL - Portela & Cª, SA

Full Title: EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093) AS ADJUNCTIVE THERAPY FOR REFRACTORY PARTIAL SEIZURES IN A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTRE CLINI...

Medical condition: simple partial seizures with no motor symptomatology Epilepsy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10065336	Partial epilepsy	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) IT (Completed) DE (Completed) GR (Completed) CY (Completed) HU (Completed) RO (Ongoing)

Trial results: View results

EudraCT Number: 2018-001581-42

Sponsor Protocol Number: 17972A

Start Date*: 2018-11-19

Sponsor Name:H. Lunbeck A/S

Full Title: Interventional, randomized, double-blind, parallel-group, placebo-controlled, fixed-flexible-dose study of Lu AF11167 for the treatment of persistent prominent negative symptoms in patients with sc...

Medical condition: schizophrenia with persistent prominent negative symptoms

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10037175 - Psychiatric disorders	10039626	Schizophrenia	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: EE (Prematurely Ended) LV (Prematurely Ended) HU (Completed) BG (Prematurely Ended) PL (Completed) CZ (Prematurely Ended)

Trial results: View results

EudraCT Number: 2020-005212-22

Sponsor Protocol Number: CC-93538-AD-001

Start Date*: 2021-09-10

Sponsor Name:Celgene International II Sàrl

Full Title: A Phase 2, Multicenter, Global, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Cendakimab (CC-93538) in Adult Subjects with Moderate to Se...

Medical condition: ATOPIC DERMATITIS

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004858	10003639	Atopic dermatitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2021-000144-21

Sponsor Protocol Number: DIUR-016-AI

Start Date*: 2022-01-14

Sponsor Name:Diurnal Limited

Full Title: A Double-Blind, Double-Dummy, Two-Way Cross-Over, Randomised, Phase II Study of Efficacy, Safety and Tolerability of Modified-Release Hydrocortisones: Chronocort® Versus Plenadren®, in Adrenal Insu...

Medical condition: Adrenal Insufficiency (AI)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10014698 - Endocrine disorders	10052381	Primary adrenal insufficiency	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2014-001132-10

Sponsor Protocol Number: OS320-3006

Start Date*: 2014-10-23

Sponsor Name:Osmotica Pharmaceutical Corp.

Full Title: A Multicenter, Randomized, Placebo-controlled, Double-blind, 26 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects with Levodo...

Medical condition: Parkinson's Disease Subjects with Levodopa-Induced Dyskinesias

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	10029205 - Nervous system disorders	10061536	Parkinson's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Prematurely Ended) FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2015-005495-19

Sponsor Protocol Number: RVT-101-2001

Start Date*: 2016-06-13

Sponsor Name:Axovant Sciences Inc.

Full Title: A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB).

Medical condition: Dementia with Lewy Bodies

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029205 - Nervous system disorders	10067889	Dementia with Lewy bodies	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) NL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2006-006967-22

Sponsor Protocol Number: R076477-SCH-3020

Start Date*: 2007-10-08

Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium

Full Title: A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects with Schizophrenia

Medical condition: Subjects 18 – 65 years of age, who meets the DSM-IV criteria for schizophrenia with a PANSS total score at screening of 60-100 inclusive.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10039626	Schizophrenia	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: LT (Completed) SE (Prematurely Ended) GR (Completed) EE (Completed) FR (Completed) GB (Prematurely Ended) IT (Completed) SK (Completed) LV (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2017-003471-54

Sponsor Protocol Number: TAK-831-2002

Start Date*: 2018-05-14

Sponsor Name:Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda

Full Title: A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose levels of TAK-831 in Adjunctive Treatment...

Medical condition: Schizophrenia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10037175 - Psychiatric disorders	10039626	Schizophrenia	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed) CZ (Completed) DE (Prematurely Ended) BG (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2020-000236-22

Sponsor Protocol Number: Study_protocol_CODEX-P_ver2_1

Start Date*: 2020-12-16

Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN)

Full Title: COPD EXacerbation and Pulmonary hypertension Trial - The effect of Sildenafil treatment to patients with COPD exacerbation and pulmonary hypertension

Medical condition: This study will investigate treatment of patients with chronic obstructive pulmonary disease (COPD), who experience frequent exacerbations (AECOPD). Only patients with a minimum of 2 moderate AECOP...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004854	10019203	Head spinning	LLT
	20.1	100000004852	10033405	Pain head	LLT
	20.0	100000004852	10019218	Headache NOS	LLT
	20.1	100000004856	10000460	Acid dyspepsia	LLT
	22.1	100000004856	10013947	Dyspepsia aggravated	LLT
	20.0	100000004856	10013948	Dyspepsia and other specified disorders of function of stomach	LLT
	21.1	100000004856	10019328	Heartburn-like dyspepsia	LLT
	20.1	100000004856	10064536	Functional dyspepsia	LLT
	23.1	100000004856	10012727	Diarrhea	LLT
	20.0	100000004859	10023222	Joint pain	LLT
	21.0	100000004859	10025012	Lumbo-sacral pain	LLT
	21.1	100000004859	10028322	Muscle pain	LLT
	20.0	100000004856	10033394	Pain epigastric	LLT
	21.1	100000004866	10016046	Facial flushing	LLT
	20.0	100000004853	10013614	Double vision	LLT
	21.0	100000004848	10005604	Blood in urine	LLT
	20.0	100000004872	10018801	Gynecomastia	LLT
	20.0	100000004872	10060603	Hematospermia	LLT
	20.0	100000004851	10002272	Anemia	LLT
	22.1	100000004853	10034961	Photophobia aggravated	LLT
	20.0	100000004871	10023139	Jaundice NOS	LLT
	20.0	100000004853	10030042	Ocular hyperemia	LLT
	20.1	100000004853	10051304	Retinal bleeding	LLT
	20.1	100000004853	10005889	Blurry vision	LLT
	20.1	100000004856	10046272	Upper abdominal pain	LLT
	20.0	100000004856	10038263	Reflux oesophagitis	LLT
	20.0	100000004856	10047706	Vomiting NOS	LLT
	20.0	100000004867	10016558	Fever	LLT
	21.1	100000004862	10024969	Lower respiratory tract infection NOS	LLT
	20.0	100000004859	10048317	Myalgia aggravated	LLT
	21.1	100000004859	10003990	Back pain (without radiation)	LLT
	20.1	100000004852	10020922	Hypesthesia	LLT
	20.0	100000004852	10027605	Migraine NOS	LLT
	21.1	100000004852	10044572	Tremor limb	LLT
	20.1	100000004852	10044570	Tremor finger	LLT
	20.0	100000004873	10002856	Anxiety attack	LLT
	20.0	100000004873	10022442	Insomnia NOS	LLT
	20.0	100000004855	10011232	Coughing	LLT
	20.0	100000004862	10040756	Sinusitis NOS	LLT
	20.0	100000004867	10014210	Edema	LLT
	20.0	100000004867	10014211	Edema (NOS)	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2005-005450-45

Sponsor Protocol Number: P04684

Start Date*: 2006-08-30

Sponsor Name:Schering-Plough Research Institute

Full Title: Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/ Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Mee...

Medical condition: Persistent Allergic Rhinitis (Allergic Rhinitis)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10039085		PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) PT (Completed) ES (Completed) DE (Completed) HU (Completed) SE (Completed) GR (Completed) DK (Completed) IT (Completed) BE (Completed) NL (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2005-005449-20

Sponsor Protocol Number: P04683

Start Date*: 2006-08-30

Sponsor Name:Schering-Plough Research Institute

Full Title: Double-Blind, Randomized, Placebo-Controlled, Parallel-Groups, Multicenter/ Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis who Me...

Medical condition: Intermittent Allergic Rhinitis (Allergic Rhinitis)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10039085		PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) PT (Completed) ES (Completed) DE (Completed) HU (Completed) SE (Completed) GR (Completed) DK (Completed) IT (Completed) BE (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2008-008135-28

Sponsor Protocol Number: 01-281108

Start Date*: 2009-04-16

Sponsor Name:Hull and East Yorkshire NHS Hospitals Trust

Full Title: Effect of Sildenafil on Pulmonary Artery Pressure during hypoxia and exercise in Chronic Heart Failure

Medical condition: We will investigate the effect of sildenafil on pulmonary artery pressure in Heart failure patients (impaired heart function). Patients will be recruited from the Heart Failure clinic at Castle Hil...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10002034	Anaemia	LLT
	9.1		10040756	Sinusitis NOS	LLT
	9.1		10016807	Fluid retention	LLT
	9.1		10022437	Insomnia	LLT
	9.1		10016998	Forehead headache	LLT
	9.1		10010108	Common migraine	LLT
	9.1		10002855	Anxiety	LLT
	9.1		10044565	Tremor	LLT
	9.1		10033987	Paresthesia	LLT
	9.1		10006790	Burning sensation NOS	LLT
	9.1		10020937	Hypoaesthesia	LLT
	9.1		10007882	Cellulitis	LLT
	9.1		10022000	Influenza	LLT
	9.1		10038870	Retinal hemorrhage	LLT
	9.1		10047544	Visual disturbance NOS	LLT
	9.1		10047513	Vision blurred	LLT
	9.1		10034960	Photophobia	LLT
	9.1		10008795	Chromatopsia	LLT
	9.1		10051819	Cyanopsia	LLT
	9.1		10015910	Eye blood shot	LLT
	9.1		10015946	Eye irritation	LLT
	9.1		10038189	Red eye	LLT
	9.1		10047531	Visual acuity reduced	LLT
	9.1		10013036	Diplopia	LLT
	9.1		10000173	Abnormal sensation in eye	LLT
	9.1		10047340	Vertigo	LLT
	9.1		10065027	Sudden deafness	LLT
	9.1		10016825	Flushing	LLT
	9.1		10006461	Bronchitis NOS	LLT
	9.1		10015090	Epistaxis	LLT
	9.1		10039092	Rhinitis NOS	LLT
	9.1		10011224	Cough	LLT
	9.1		10028735	Nasal congestion	LLT
	9.1		10012735	Diarrhoea	LLT
	9.1		10013946	Dyspepsia	LLT
	9.1		10017869	Gastritis NOS	LLT
	9.1		10017888	Gastroenteritis	LLT
	9.1		10017885	Gastrooesophageal reflux disease	LLT
	9.1		10019022	Haemorrhoids	LLT
	9.1		10000060	Abdominal distension	LLT
	9.1		10013781	Dry mouth	LLT
	9.1		10001760	Alopecia	LLT
	9.1		10015150	Erythema	LLT
	9.1		10029410	Night sweats	LLT
	9.1		10040913	Skin rash	LLT
	9.1		10028411	Myalgia	LLT
	9.1		10003988	Back pain	LLT
	9.1		10018800	Gynaecomastia	LLT
	9.1		10036661	Priapism	LLT
	9.1		10052791	Erection increased (excl priapism)	LLT
	9.1		10037660	Pyrexia	LLT
	9.1		10042438	Sudden hearing loss, unspecified	LLT
	9.1		10033425	Pain in extremity	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-000350-31

Sponsor Protocol Number: CENA713B2315

Start Date*: 2008-01-22

Sponsor Name:Novartis Pharma AG

Full Title: A 76-week prospective, open-label, multicenter study to evaluate the long-term effect of Exelon® capsule and transdermal patch on worsening of the underlying motor symptoms of PD in patients with m...

Medical condition: Mild to moderately severe dementia associated with Parkinson’s disease (PDD).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012284	Dementia due to Parkinson's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2010-021394-37

Sponsor Protocol Number: SP0976

Start Date*: 2011-03-08

Sponsor Name:UCB Pharma SA

Full Title: MULTICENTER, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, PHASE IV STUDY TO ASSESS THE EFFECT OF ROTIGOTINE ON NON-MOTOR SYMPTOMS IN PATIENTS WITH IDIOPATHIC PARKINSON’S DISEASE

Medical condition: Parkinson's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029205 - Nervous system disorders	10061536	Parkinson's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) BE (Completed) CZ (Completed) SK (Completed) ES (Completed) AT (Completed) BG (Completed) IT (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Sleep Disorder